Onconetix Inc. (ONCO)
NASDAQ: ONCO
· Real-Time Price · USD
2.94
-0.15 (-4.85%)
At close: Aug 15, 2025, 3:59 PM
2.91
-1.14%
After-hours: Aug 15, 2025, 07:31 PM EDT
Onconetix Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Mar 31, 2021 |
Revenue | 1.93M | 2.52M | 1.87M | 1.46M | 758.9K | 58.47K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 1.01M | 1.5M | 2.64M | 2.34M | 1.74M | 1.2M | 6.73K | 6.96K | 7.15K | 6.75K | 6.06K | 5.47K | 4.94K | 3.64K | 2.49K | 1.23K |
Gross Profit | 911.93K | 1.02M | -771.15K | -878.18K | -980.47K | -1.14M | -6.73K | -6.96K | -7.15K | -6.75K | -6.06K | -5.47K | -4.94K | -3.64K | -2.49K | -1.23K |
Operating Income | -57.98M | -49M | -25.25M | -27.09M | -20.13M | -19.38M | -17.23M | -16.61M | -14.26M | -13.12M | -11.08M | -8.3M | -4.33M | -2.63M | -1.42M | -325.78K |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -57.04M | -59.74M | -51.74M | -53.21M | -45.82M | -37.42M | -18.28M | -16.8M | -14.2M | -13.42M | -11.41M | -8.63M | -4.7M | -2.63M | -1.42M | -325.78K |
Net Income | -56.12M | -58.69M | -51.6M | -53.12M | -45.68M | -37.41M | -18.28M | -16.8M | -14.2M | -13.42M | -11.41M | -8.63M | -4.7M | -2.63M | -1.42M | -325.78K |
Selling & General & Admin | 9.2M | 11.23M | 12.83M | 14.45M | 14.54M | 12.6M | 10.38M | 8.8M | 9.5M | 8.98M | 7.71M | 5.84M | 3.08M | 1.83M | 1.06M | 236.31K |
Research & Development | 129.85K | 154.36K | -44.27K | 65.6K | 916.13K | 1.95M | 3.35M | 4.31M | 4.76M | 4.13M | 3.36M | 2.46M | 1.25M | 795.49K | 358.16K | 88.24K |
Other Expenses | 49.56M | 38.64M | 15.76M | 15.76M | 4.26M | 4.26M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 58.29M | 49.42M | 23.88M | 25.61M | 15.65M | 14.74M | 13.73M | 13.11M | 14.25M | 13.11M | 11.07M | 8.3M | 4.33M | 2.62M | 1.42M | 324.55K |
Interest Expense | 1.22M | 1.41M | 1.35M | 1.23M | 1.08M | 671.63K | 483.09K | 214K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | -2.17M | -2.17M | -2.17M | -2.17M | -1.85K | -1.85K | -1.85K | -1.85K | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 59.3M | 50.92M | 26.52M | 27.95M | 17.39M | 15.94M | 13.73M | 13.11M | 14.26M | 13.12M | 11.08M | 8.3M | 4.33M | 2.63M | 1.42M | 325.78K |
Income Tax Expense | -923.61K | -1.05M | -139.78K | -83.39K | -134.16K | -14.21K | -1.61K | -1.61K | -1.61K | 9.00 | 2.00 | -3 | -5 | -5 | -2 | -2 |
Shares Outstanding (Basic) | 5.34K | 2.75M | 1.31M | 22.2M | 22.15M | 22.32M | 17.52M | 15.91M | 15.91M | 15.27M | 14.34M | 12M | 6.34M | 11.05M | 11.05M | 3.2M |
Shares Outstanding (Diluted) | 5.34K | 2.75M | 1.31M | 22.2M | 22.15M | 22.32M | 17.52M | 15.91M | 15.91M | 15.27M | 14.34M | 12M | 6.34M | 11.05M | 11.05M | 3.2M |
EPS (Basic) | -1.82K | -21.45 | -5.07 | -2.45 | -2.24 | -1.92 | -1.13 | -1.09 | -1.02 | -1.17 | -1.07 | -0.9 | -0.64 | -0.31 | -0.2 | -0.1 |
EPS (Diluted) | -1.82K | -21.45 | -5.07 | -2.45 | -2.24 | -1.92 | -1.13 | -1.09 | -1.02 | -1.17 | -1.07 | -0.9 | -0.64 | -0.31 | -0.2 | -0.1 |
EBITDA | -55.29M | -57.6M | -49.74M | -51.53M | -44.48M | -36.71M | -17.81M | -16.6M | -14.22M | -13.44M | -11.4M | -8.63M | -4.69M | -2.62M | -1.42M | -324.55K |
EBIT | -55.82M | -58.33M | -50.4M | -51.97M | -44.73M | -36.75M | -17.82M | -16.61M | -14.22M | -13.45M | -11.41M | -8.63M | -4.7M | -2.63M | -1.42M | -325.78K |
Depreciation & Amortization | 529.39K | 731.35K | 651.1K | 448.67K | 248.94K | 43.94K | 6.73K | 6.96K | 7.15K | 6.75K | 6.06K | 5.47K | 4.94K | 3.64K | 2.49K | 1.23K |